Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/53946

Liquid fructose down-regulates liver insulin receptor substrate 2 and gluconeogeneic enzymes by modifying nutrient sensing factors in rats
Rebollo de Grado, Alba; Roglans i Ribas, Núria; Baena Muñoz, Miguel; Padrosa, Anna; Sánchez Peñarroya, Rosa M.; Merlos Roca, Manuel; Alegret i Jordà, Marta; Laguna Egea, Juan Carlos
Universitat de Barcelona
High consumption of fructose-sweetened beverages has been linked to a high prevalence of chronic metabolic diseases. We have previously shown that a short course of fructose supplementation as a liquid solution induces glucose intolerance in female rats. In the present work, we characterized the fructose-driven changes in the liver and the molecular pathways involved. To this end, female rats were supplemented or not with liquid fructose (10%, w/v) for 7 or 14 days. Glucose and pyruvate tolerance tests were performed, and the expression of genes related to insulin signaling, gluconeogenesis and nutrient sensing pathways was evaluated. Fructose-supplemented rats showed increased plasma glucose excursions in glucose and pyruvate tolerance tests and reduced hepatic expression of several genes related to insulin signaling, including insulin receptor substrate 2 (IRS-2). However, the expression of key gluconeogenic enzymes, glucose-6-phosphatase and phosphoenolpyruvate carboxykinase, was reduced. These effects were caused by an inactivation of hepatic forkhead box O1 (FoxO1) due to an increase in its acetylation state driven by a reduced expression and activity of sirtuin 1 (SIRT1). Further contributing to FoxO1 inactivation, fructose consumption elevated liver expression of the spliced form of X-box-binding-protein-1 as a consequence of an increase in the activity of the mammalian target of rapamycin 1 and protein 38-mitogen activated protein kinase (p38-MAPK). Liquid fructose affects both insulin signaling (IRS-2 and FoxO1) and nutrient sensing pathways (p38-MAPK, mTOR and SIRT1), thus disrupting hepatic insulin signaling without increasing the expression of key gluconeogenic enzymes.
-Resistència a la insulina
-Fetge
-Fructosa
-Insulin resistance
-Liver
-Fructose
(c) Elsevier B.V., 2014
Artículo
Artículo - Versión aceptada
Elsevier B.V.
         

Mostrar el registro completo del ítem

Documentos relacionados

Otros documentos del mismo autor/a

Rebollo de Grado, Alba; Roglans i Ribas, Núria; Baena Muñoz, Miguel; Sánchez Peñarroya, Rosa M.; Merlos Roca, Manuel; Alegret i Jordà, Marta; Laguna Egea, Juan Carlos
Rebollo de Grado, Alba; Baena Muñoz, Miguel; Roglans i Ribas, Núria; Alegret i Jordà, Marta; Laguna Egea, Juan Carlos
Alegret i Jordà, Marta; Camarasa García, Jordi; Camins Espuny, Antoni; Canudas Teixidó, Anna-Maria; Cañigueral i Folcarà, Salvador; Escubedo Rafa, Elena; Freixa de Reynoso, Blanca; Marin Parés, Esther; Jiménez Guerrero, Andrés; Laguna Egea, Juan Carlos; Merlos Roca, Manuel; Pallàs i Llibería, Mercè, 1964-; Palomer Tarridas, Francesc Xavier; Pérez García, Francisco (Professor); Pubill Sánchez, David; Sánchez Peñarroya, Rosa M.; Rimbau i Barreras, Víctor; Roglans i Ribas, Núria; Vázquez Carrera, Manuel; Vila Casanovas, Roser
Vilà Prats, Laia; Roglans i Ribas, Núria; Baena Muñoz, Miguel; Barroso Fernández, Emma; Alegret i Jordà, Marta; Merlos Roca, Manuel; Laguna Egea, Juan Carlos
Hutter, Natalia; Baena Muñoz, Miguel; Sangüesa Puigventós, Gemma; Dávalos, Albert; Latasa, María Jesús; Escolà i Gil, Joan Carles; Sánchez Peñarroya, Rosa M.; Roglans i Ribas, Núria; Alegret i Jordà, Marta; Laguna Egea, Juan Carlos